STRA8 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:346673, HGNC:30653, MIM:609987, NM_182489, NP_872295, STRA8, XM_011516137, XM_011516138, XM_011516139, XM_017012150, XP_011514439, XP_011514440, XP_011514441, XP_016867639, stimulated by retinoic acid 8

Id:ENSG00000146857

Entrez:346673

Ensembl:ENSG00000146857

Description:stimulated by retinoic acid 8

This gene encodes a retinoic acid-responsive protein. A homologous protein in mouse has been shown to be involved in the regulation of meiotic initiation in both spermatogenesis and oogenesis, though feature differences between the mouse and human proteins suggest that these homologs are not entirely functionally equivalent. It is thought that this gene may play a role in spermatogenesis in humans. [provided by RefSeq, Nov 2010]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View STRA8's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with STRA8.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using STRA8.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for STRA8.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with STRA8.

Results found

Linked to

	Label	Description
	GSE255432 7 V 3 IMEGLIMIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 2 V 1 GEMCITABINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE129698 SYK inhibition 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126463 pomalidomide MM1.S 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE126463 4 V 2 POMALIDOMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 1 V 4 DECITABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE133661 C19orf12 knockdown A-549 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172494 nicotinamide 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE255432 7 V 3 IMEGLIMIN MOUSE UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE165548 2 V 1 GEMCITABINE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE218060 decitabine T cell 1 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE129698 SYK inhibition 1 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE126463 pomalidomide MM1.S 4 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE126463 4 V 2 POMALIDOMIDE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE218060 1 V 4 DECITABINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE133661 C19orf12 knockdown A-549 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE172494 nicotinamide 3 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.